gammanorm 165 mg/ml raztopina za injiciranje
octapharma (ip) sprl - polispecifični imunoglobulin, humani - raztopina za injiciranje - polispecifični imunoglobulin, humani 165 mg / 1 ml - humani imunoglobulini za ekstravaskularno aplikacijo
gammanorm 165 mg/ml raztopina za injiciranje
octapharma (ip) sprl - polispecifični imunoglobulin, humani - raztopina za injiciranje - polispecifični imunoglobulin, humani 165 mg / 1 ml - humani imunoglobulini za ekstravaskularno aplikacijo
gammanorm 165 mg/ml raztopina za injiciranje
octapharma (ip) ltd., - polispecifični imunoglobulin, humani - raztopina za injiciranje - polispecifični imunoglobulin, humani 165 mg / 1 ml - humani imunoglobulini za ekstravaskularno aplikacijo
gammanorm 165 mg/ml raztopina za injiciranje
octapharma (ip) ltd., - polispecifični imunoglobulin, humani - raztopina za injiciranje - polispecifični imunoglobulin, humani 165 mg / 1 ml - humani imunoglobulini za ekstravaskularno aplikacijo
hepatect cp 50 i.e./ml raztopina za infundiranje
biotest pharma gmbh - imunoglobulin proti hepatitisu b, humani - raztopina za infundiranje - imunoglobulin proti hepatitisu b, humani 50 i.e. / 1 ml - humani imunoglobulin proti hepatitisu tipa b
octagam 100 mg/ml raztopina za infundiranje
octapharma (ip) sprl - polispecifični imunoglobulin, humani - raztopina za infundiranje - polispecifični imunoglobulin, humani 100 mg / 1 ml - humani imunoglobulini za intravaskularno aplikacijo
td-pur suspenzija za injiciranje
gsk vaccines gmbh - davični toksoid; tetanusni toksoid - suspenzija za injiciranje - davični toksoid 2 i.e. / 0,5 ml tetanusni toksoid20 i.e. / 0,5 ml; tetanusni toksoid 20 i.e. / 0,5 ml - tetanusni toksoid v kombinaciji z davičnim toksoidom
tetanol pur 40 i.e. suspenzija za injiciranje
gsk vaccines gmbh - tetanusni toksoid - suspenzija za injiciranje - tetanusni toksoid 40 i.e. / 0,5 ml - tetanusni toksoid
octagam 100 mg/ml raztopina za infundiranje
polispecifični imunoglobulin, humani - raztopina za infundiranje - polispecifični imunoglobulin, humani 100 mg / 1 ml - humani imunoglobulini za intravaskularno aplikacijo
revolade
novartis europharm limited - eltrombopag - purpura, trombocitopenična, idiopatska - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 in 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 in 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.